EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock closed at $19.94 on 5/2/24 after a major increase of 10.5%. Moreover, exceptionally high trading volume at 216% of normal accompanied the advance. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 21.1% during the last week.
Current PriceTarget Research Rating
EYPT is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
EyePoint Pharmaceuticals has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. EyePoint Pharmaceuticals has a poor Appreciation Score of 17 but a very high Power Rating of 95, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment